As part of its landmark $18.5 billion deal to buy Livongo, telehealth giant Teladoc Health is poised to inherit a set of devices that the chronic care company has used for years to turn mountains of ...
Virtual care giants Teladoc Health and Livongo Health said Wednesday Aug. 5 they would merge in a $18.5 billion deal. Telehealth giant Teladoc Health said Wednesday it would buy Livongo Health in a ...
If you'd been able to buy at Livongo's IPO price of $28, an initial investment of $10,000 would have given you 357 shares. If we assume you didn't buy partial shares, you would've had a few bucks left ...
Digital healthcare company Livongo received an emergency use authorization Wednesday from the U.S. Food and Drug Administration to use their remote blood glucose meter in hospitals. The San ...
After Teladoc’s massive merger with Livongo, several of the digital health startup’s top leaders will depart. Livongo President Dr. Jennifer Schneider, who held a public role with the company, and ...
After his digital health startup Livongo sold to Teladoc for $18.5 billion, Glen Tullman has found his next venture. He’s leading a health navigation startup called Transcarent, which sets itself ...
Livongo is one of the first digital health companies to file for an initial public offering. The company provide tools for people with chronic disease, and works with some 600 employers and health ...
MOUNTAIN VIEW, Calif., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and ...
It took a lot of late-night and early-morning Zoom calls plus some socially distanced in-person meetings to create the first health tech giant, all conducted during a pandemic and in near-total ...
One stock that might be an intriguing choice for investors right now Livongo Health, Inc., LVGO. This is because this security in the Medical Info Systems space is seeing solid earnings estimate ...
Telehealth giant Teladoc and digital chronic disease management company Livongo announced an $18.5 billion merger that'll value the combined entity at $37 billion. This deal arrives as both companies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results